Servier India launches ‘Ivosidenib' Tibsovo
Kochi, Jun 10 (UNI) Servier India, a subsidiary of the leading French pharmaceutical Servier Group, has announced the launch of Ivosidenib (Tibsovo®), an oral targeted therapy approved in the management of cancer patients with Acute Myeloid Leukemia (AML) and Cholangiocarcinoma, with an isocitrate dehydrogenase-1 (IDH1) mutation.
Servier India received the approval on 14th May 2025, from Central Drugs Standard Control Organisation (CDSCO) for the import, sale, and distribution of the medication.
Acute myeloid leukemia is a challenging hematological malignancy. Studies indicate that only about 30–40 percent of AML patients in India receive adequate treatment, with high mortality rates due to rapid disease progression and infections.
Cholangiocarcinomas (CCA) are rare tumours originating from the bile duct. Due to their asymptomatic nature, they are usually diagnosed when the disease is advanced.
The announcement marks a significant advancement in the management of the mentioned rare and difficult-to-treat cancers in India, addressing a critical unmet medical need.
Aurélien Breton, Managing Director, Servier India, said, 'Our focus is to advance oncology care by bringing innovative, precision medicines to patients who need them the most."
"By prioritizing access and working to make treatment options affordable to patients, we are dedicated to bridging critical gaps in cancer care across the country. This launch will support healthcare providers with targeted treatment options and ultimately improve survival outcomes and quality of life for patients throughout India.'
IDH1 mutation occurs in approximately 7–14 percent of AML patients in India, making targeted mechanisms especially relevant for this subset.
'This therapy represents a significant therapeutic option in the treatment of AML and Cholangiocarcinoma. For healthcare professionals, this precision therapy offers a new, effective option that can improve patient outcomes where traditional treatments have limited success. It highlights the benefits of targeted therapy and caliber of innovation in enhancing lives and advancing cancer care in India.', highlighted Dr. Pranav Sopory, Medical and Patient Affairs Director, Servier India.
By introducing these advanced therapies, Servier India reaffirms its commitment to advancing innovative cancer treatments that improve clinical outcomes and enhance the quality of life of patient.
UNI DS BD
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
4 hours ago
- Time of India
Crunchy culprit: Study shows how to tackle acrylamide in French fries
Ahmedabad: That satisfying crunch in French fries and toasted sandwiches might be coming at a hidden cost. The crunch is attributed to a substance identified as acrylamide, which gives the distinct brown colour to deep-fried foods. According to several studies, the substance is linked to various gastrointestinal (GI) issues and can even lead to cancer if consumed very frequently. Research carried out at IIT Gandhinagar (IIT-Gn) addressed the issue by using amino acid adducts (AAA). The findings were published in the form of a paper titled 'Sequestration of acrylamide as amino acid-acrylamide adducts mitigates cellular stress in human gastrointestinal cell lines' recently in the journal, Food and Function, of the UK-based Royal Society of Chemistry. The authors were Axita Patel and Prof Bhaskar Datta. "Starchy foods exposed to frying, baking or roasting are vulnerable to forming acrylamide through a chemical reaction between a natural sugar (glucose) and an amino acid (asparagine). This reaction is identified as the Maillard reaction. Acrylamide is commonly found in fried potato products (French fries, chips), biscuits, toast, cookies and coffee, to name a few," said Prof Datta. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Irish homeowners eligible for solar 'bonus' if they live in these eircodes Activ8 Learn More Undo "Before its association with food, it was always associated with the chemical industry as a versatile petrochemical. " The researchers said that the rise in foods prepared at high temperatures has resulted in higher exposure to acrylamide. Acrylamide's toxic effects create oxidative stress, which affects cells in the GI tract, causing inflammation, tissue damage and even cancer. Prof Datta said that to counter acrylamide, they employed AAA. The interaction of AAA as a 'treatment agent' indicated significantly lower production of acrylamide. The team used amino acids lysine, glycine, cysteine and methionine to form stable adducts to capture acrylamide. The team is also working on sprinkle-type formulations that can be applied to raw potatoes before frying. "The study opens a new way to look at 'capturing' acrylamide to reduce its harmful effects through specific amino acids and also underlines the reason for avoiding fried starchy food not only for cholesterol but also for acrylamide. Regular consumption of antioxidants is also important," said Prof Datta. He gave a practical tip to French fries enthusiasts. "As evident in our work, a simple blanching of potatoes (briefly submerged in very hot water and then quickly cooled in ice water) before they are fried can reduce the acrylamide content," he said.
United News of India
8 hours ago
- United News of India
Steps taken to eradicate Tuberculosis, AIDS
Kollam, Jun 22 (UNI) The TB Elimination and AIDS Prevention Control Committee has emphasised on the need to expand awareness initiatives and conduct more camps for eliminating these two serious illnesses. The decision regarding this was taken by the Committee under the chairmanship of District Collector N. Devadas. Steps have been taken to intensify tuberculosis and AIDS eradication efforts in this district of Kerala. TB diagnostic camps will be organized in areas where a high number of migrant workers reside. Individuals with more serious respiratory issues will be referred for expert treatment. If required, isolation centers will be considered for treating such patients. With the support of local self-government institutions, nutritious food kits will be distributed to patients. Special camps were conducted in the coastal region from Paravur to Azhikode, and awareness stickers were affixed on hundreds of boats. Awareness messages were disseminated not only in Malayalam but also in Tamil and Hindi. AIDS awareness among youth will continue with the cooperation of various government departments. UNI DS RKM
United News of India
12 hours ago
- United News of India
Former England fast bowler Lawrence dies
London, June 22 (UNI) Former England and Gloucestershire fast bowler David 'Syd' Lawrence has died at the age of 61. Lawrence, the first British-born black cricketer to represent England, was diagnosed with motor neurone disease (MND) last year. He was appointed MBE in the King's Birthday Honours earlier this month after raising money and awareness of the condition. Lawrence played five Test matches for England and took 625 wickets in 280 matches during a 16-year career at Gloucestershire. "'Syd' was an inspirational figure on and off the cricket field and no more so than to his family who were with him when he passed," said a family statement announcing his death. He made his first-class debut for the county in 1981, gaining the nickname Syd after the British bandleader, according to a BBC news. Lawrence went on to take three wickets on his Test debut against Sri Lanka at Lord's in 1988. A bowler capable of reaching extreme pace, Lawrence did not play again for England until 1991 when he took 14 wickets across three Tests and played his sole one-day international the same summer. However, his career was curtailed by a serious knee injury suffered while playing for England against New Zealand the following winter. He played four County Championship matches in a comeback in 1997 but did not play again in top-level cricket afterwards. After retirement he became a nightclub owner and amateur bodybuilder before being named Gloucestershire's club president in 2022. He continued in the role after his MND diagnosis last year and has been a prominent campaigner to support those with the disease. UNI BM
